![]() |
|
|
Vol. 299, Issue 1, 277-289, October 2001
Division of Neuropharmacology, Center of Alcohol Studies, Rutgers
University, Piscataway, New Jersey
The 5-hydroxytryptamine (5-HT)2A receptor is an important
component of the neural substrates underlying ethanol (EtOH) intake and
behaviors related to anxiety and stress. Paradoxically, both 5-HT2A agonists and antagonists have been shown to reduce
EtOH intake, however the mechanisms underlying these effects are not understood. This inconsistency could possibly be explained by their
chronic down-regulation of the 5-HT2A receptor. To further address these findings, the present study sought to functionally characterize the role of localized 5-HT2A receptors in
regulating EtOH ingestion by producing central nervous system
site-specific receptor down-regulation through infusion of antisense
oligonucleotide (ASO). Rats were infused with 5-HT2A
receptor ASO into the lateral ventricle (i.c.v.), prefrontal
cortex (PFC), central amygdaloid nucleus, medial and lateral division
(CeA/L), dorsal raphe nucleus (DRN), or hippocampus (HIP) for a period
of 26 days. Subjects were tested for EtOH intake and behaviors related
to anxiety and stress. ASO administration i.c.v. and into the CeA/L
significantly reduced EtOH intake. PFC 5-HT2A ASO
administration increased EtOH intake. Administration of
5-HT2A ASO into the DRN and HIP had no effect on EtOH
intake. Intracerebroventricular ASO administration increased activity
in a novel open field and increased anxiety-like behavior in the
elevated plus maze. PFC ASO administration produced an anxiogenic
effect in the elevated plus maze. Intracerbroventricular, PFC, and
CeA/L ASO infusions altered adrenocortical function. These differential
behavioral effects specific to the anatomical locations targeted for
5-HT2A receptor down-regulation may help resolve a
long-standing, apparent inconsistency in the role of 5-HT2A
receptors in EtOH consumption.